Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03708068Not ApplicableCompleted

Early Exclusive Enteral Nutrition in Early Preterm Infants

Role: lead

NCT03637413Not ApplicableUnknown

Effect of Hindmilk on Growth Velocity of Very Preterm Infants

Role: lead

NCT03422562Phase 3Completed

Probiotics and Intestinal Microbiome in Preterm Infants

Role: lead

NCT03594474Not ApplicableCompleted

Early Higher Intravenous Lipid Intake in VLBW Infants

Role: lead

All 4 trials loaded